🇺🇸 FDA
Patent

US 10238599

Composition and method for treating congenital cytomegalovirus induced hearing loss

granted A61KA61K2300/00A61K31/015

Quick answer

US patent 10238599 (Composition and method for treating congenital cytomegalovirus induced hearing loss) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K2300/00, A61K31/015, A61K31/05, A61K31/07